7Baggers
 published on: 2025-09-19 23:06:32  newser.com Sat, 20 Sep 2025 04:06:32 GMT
 published on: 2025-09-19 03:12:27  خودرو بانک Thu, 18 Sep 2025 23:44:22 GMT
 published on: 2025-09-19 03:17:40  khodrobank.com Thu, 18 Sep 2025 11:48:36 GMT
 PDS Biotech Sets Significant Benchmark in Head and Neck  GlobeNewswire Thu, 18 Sep 2025 07:00:00 GMT
 PDS Biotechnology Announces VERSATILE-002 Trial Success  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 PDS Biotech reports 29.5-month survival in head and neck cancer trial  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 published on: 2025-09-14 15:09:06  newser.com Sun, 14 Sep 2025 20:09:06 GMT
 published on: 2025-09-13 16:30:54  newser.com Sat, 13 Sep 2025 21:30:54 GMT
 published on: 2025-09-12 13:48:31  Newser Fri, 12 Sep 2025 18:48:31 GMT
 published on: 2025-09-12 12:57:47  Newser Fri, 12 Sep 2025 17:57:47 GMT
 published on: 2025-09-11 00:30:19  Newser Thu, 11 Sep 2025 05:30:19 GMT
 published on: 2025-09-10 23:44:38  Newser Thu, 11 Sep 2025 04:44:38 GMT
 published on: 2025-09-02 23:19:15  Newser Wed, 03 Sep 2025 04:19:15 GMT
 published on: 2025-09-02 06:52:13  Newser Tue, 02 Sep 2025 11:52:13 GMT

PDS Biotechnology Corporation
(NASDAQ:PDSB) 

PDSB stock logo

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cance...

Founded: 2005
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends